Jonathan Lieber
Director of Finance/CFO at RALLYBIO CORPORATION
Net worth: 9 717 $ as of 30/04/2024
Jonathan Lieber active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Director/Board Member | 19/06/2020 | - |
| Independent Dir/Board Member | 19/06/2020 | - | |
| RALLYBIO CORPORATION | Director of Finance/CFO | 01/02/2023 | - |
| Treasurer | 01/02/2023 | - | |
Atrius Health, Inc.
 Atrius Health, Inc. Medical/Nursing ServicesHealth Services Atrius Health, Inc. provides healthcare services. It offers a variety of programs for patients with asthma, heart disease, diabetes, AIDS, and cancer. Its services include CT scan, endoscopy, mammography, and weight management. The company was founded in 1969 and is headquartered in Newton, MA. | Corporate Officer/Principal | - | - |
Career history of Jonathan Lieber
Former positions of Jonathan Lieber
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Director of Finance/CFO | 20/09/2021 | 30/11/2022 |
| ORGANOVO HOLDINGS, INC. | Director of Finance/CFO | 13/05/2021 | 06/10/2021 |
| President | 13/05/2021 | 06/10/2021 | |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Chief Executive Officer | 01/12/2018 | 07/04/2021 |
| Director of Finance/CFO | 01/12/2018 | 01/09/2021 | |
| CHECKMATE PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/07/2019 | 04/01/2021 |
| OCUGEN, INC. | Comptroller/Controller/Auditor | 01/06/2015 | 01/12/2018 |
| Director of Finance/CFO | 01/06/2015 | 01/12/2018 | |
| Treasurer | 01/06/2015 | 01/12/2018 | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Director of Finance/CFO | 29/01/2014 | 01/06/2015 |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jonathan Lieber
| Boston University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| United States | 15 |
| Israel | 2 |
| 2 |
Operational
| Director of Finance/CFO | 10 |
| Treasurer | 5 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 9 |
| Finance | 4 |
| Health Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| RALLYBIO CORPORATION | Health Technology |
| Private companies | 11 |
|---|---|
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Atrius Health, Inc.
Atrius Health, Inc. Medical/Nursing ServicesHealth Services Atrius Health, Inc. provides healthcare services. It offers a variety of programs for patients with asthma, heart disease, diabetes, AIDS, and cancer. Its services include CT scan, endoscopy, mammography, and weight management. The company was founded in 1969 and is headquartered in Newton, MA. | Health Services |
| Salomon Brothers, Inc. | Finance |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Finance |
| Salarius Pharmaceuticals, Inc. | |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jonathan Lieber
- Experience
